logo
Select company
Select metric
$ 1.2BCore Assets
VS
Market
58
Sector
87
Industry
96
History
100
$ 5.86Close
$ 1.93 - $ 6.17 52-Week Range
Ticker Information

Ticker

ABCL

Company Name

ABCELLERA BIOLOGICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

ABCELLERA BIOLOGICS INC - Core Assets Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

ABCL - Core Assets Historical data
DateTotal AssetsCash and EquivalentsCore AssetsGoodwill and Intangibles
6/30/2025$ 1.4B$ 117.44M$ 1.2B$ 88.07M
3/31/2025$ 1.34B$ 184.27M$ 1.07B$ 89M
12/31/2024$ 1.36B$ 181.32M$ 1.09B$ 89.92M
9/30/2024$ 1.39B$ 151.64M$ 1.14B$ 100.38M
6/30/2024$ 1.41B$ 173.31M$ 1.11B$ 133.47M
3/31/2024$ 1.46B$ 148.57M$ 1.15B$ 166.54M
12/31/2023$ 1.49B$ 158.32M$ 1.16B$ 168.23M
9/30/2023$ 1.51B$ 197.42M$ 1.14B$ 171.88M
6/30/2023$ 1.54B$ 204.75M$ 1.16B$ 174.55M
3/31/2023$ 1.5B$ 218.02M$ 1.1B$ 176.65M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • ABCELLERA BIOLOGICS INC's latest trailing twelve months (TTM) Core Assets stands at $ 15.94M.
  • Over the past 5 years, ABCELLERA BIOLOGICS INC's average Core Assets has been $ 788.54M.
  • The median Core Assets for ABCELLERA BIOLOGICS INC during this period was $ 965.08M
  • ABCELLERA BIOLOGICS INC reached its highest Core Assets over the past 5 years at $ 1.2B.
  • The lowest Core Assets recorded by ABCELLERA BIOLOGICS INC in the same timeframe $ 15.94M

ABCELLERA BIOLOGICS INC's Core Assets vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Core Assets Benchmarks
CompanyCore Assets
MGTX : MEIRAGTX HOLDINGS PLC $ 163.55MAUTL : AUTOLUS THERAPEUTICS PLC $ 582.72MNTLA : INTELLIA THERAPEUTICS INC $ 742.72MTNGX : TANGO THERAPEUTICS INC $ 198.19MFENC : FENNEC PHARMACEUTICALS INC $ 26.17MGOSS : GOSSAMER BIO INC $ 214.62MSSII : SS INNOVATIONS INTERNATIONAL INC $ 52.72MVIR : VIR BIOTECHNOLOGY INC $ 868.27MCCCC : C4 THERAPEUTICS INC $ 214.93MIMNM : IMMUNOME INC $ 152.2M

Definition of Core Assets

[Calculation] The core assets of a company represents the total [Assets] minus cash & equivalents [CashnEq] minus intangibles & goodwill [Intangibles].
Assets - Intangibles - CashnEq
(=) Core Assets
Core Assets for ABCELLERA BIOLOGICS INC is calculated as follows: Assets [ $ 23.49M ] - Intangibles [ $ 0 ] - CashnEq [ $ 7.55M ]
(=) Core Assets [ $ 15.94M ]

ABCL - Core Assets, Last 5 years

$ 15.94M

Minimum

Dec 31, 2019

$ 1.2B

Maximum

Jun 30, 2025

$ 788.54M

Average

$ 965.08M

Median

Core Assets Benchmark Analysis

The chart above depicts the distribution of Core Assets for companies in the Total Stock Market. The average Core Assets of the companies is $ 798.38M with a standard deviation of $ 1.05B.
The following table provides additional summary stats:
Core Assets in the Market:
filtered constituents3.42K
min$ 0
max$ 4.36B
average$ 798.38M
median$ 287.61M
std$ 1.05B